FIGURE 8.
E2F1 promotes the malignant biological traits of STS cell lines. (A) Knockdown efficiency for E2F1 in hSS-005R cell lines. (B) CCK-8 assay between hSS-005R cell lines treated with E2F1 siRNA versus those treated with control siRNA. (C) Clone formation between hSS-005R cell lines treated with E2F1 siRNA versus those treated with control siRNA. (D) Scratch assay between hSS-005R cell lines treated with E2F1 siRNA versus those treated with control siRNA.
